An interventional, single arm, multicenter, phase I/IIa clinical trial to investigate the efficacy and safety of allo-APZ2-CVU on wound healing of chronic venous ulcer (CVU).
Phase of Trial: Phase I/II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs APZ 2 (Primary)
- Indications Varicose ulcer
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors RHEACELL
- 21 Sep 2017 Status changed from recruiting to suspended.
- 28 Aug 2017 Status changed from not yet recruiting to recruiting.
- 11 Aug 2017 New trial record